Vascular imaging findings in retinopathy of prematurity.
Lucas W RoweAditya V BelamkarGal AntmanAmir Reza HajrasoulihaAlon HarrisPublished in: Acta ophthalmologica (2023)
Retinopathy of prematurity (ROP) is a vascular disease among preterm infants involving incomplete or abnormal retinal vascularization and is a leading cause of preventable blindness globally. Measurements of ocular blood flow originating from a variety of imaging modalities, including colour Doppler imaging (CDI), fluorescein angiography (FA) and ocular coherence tomography angiography (OCTA), have been associated with changes in ROP patients. Herein, we discuss and summarize the relevant current literature on vascular imaging and ROP reviewed through December 2022. Differences in vascular imaging parameters between ROP patients and healthy controls are reviewed and summarized. The available data identify significantly increased peak systolic velocity (PSV) in the central retinal artery and ophthalmic artery as measured by CDI, increased vascular tortuosity as measured by FA, smaller foveal avascular zone (FAZ) as measured by FA and OCTA, and increased foveal vessel density (VD) and reduced parafoveal VD as measured by OCTA in ROP patients compared with controls. None of the above findings appear to reliably correlate with visual acuity. The studies currently available, however, are inconclusive and lack robust longitudinal data. Vascular imaging demonstrates the potential to aid in the diagnosis, management and monitoring of ROP, alongside retinal examination via indirect ophthalmoscopy and fundus photography.
Keyphrases
- optical coherence tomography
- high resolution
- end stage renal disease
- blood flow
- ejection fraction
- newly diagnosed
- preterm infants
- chronic kidney disease
- peritoneal dialysis
- heart failure
- emergency department
- left ventricular
- risk assessment
- electronic health record
- patient reported
- patient reported outcomes
- artificial intelligence